YZYuxin Zhang

Yuxin Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yuxin Zhang has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Fengwu Chen

    National Clinical Research Center for Hematologic Diseases, Cyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, Jiangsu Key Laboratory of Radiation Injury Prevention and Hazardous Substance Control, Soochow University, Suzhou, China (F.C., X.Y., Z.Z., A.Y., Y.L., Y.W.).

    3 shared publications
  • Yi Wu

    Soochow University

    3 shared publications
  • Yue Han

    National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China

    2 shared publications
  • Yue Lu

    National Clinical Research Center for Hematologic Diseases, Cyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Prevention, Soochow University, Suzhou, China

    2 shared publications
  • Aizhen Yang

    National Clinical Research Center for Hematologic Diseases, Cyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Prevention, Soochow University, Suzhou, China

    1 shared publication
  • Aizhen Yang

    National Clinical Research Center for Hematologic Diseases, Cyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, Jiangsu Key Laboratory of Radiation Injury Prevention and Hazardous Substance Control, Soochow University, Suzhou, China (F.C., X.Y., Z.Z., A.Y., Y.L., Y.W.).

    1 shared publication

Latest Publications

  • Transmembrane Protein Disulfide Isomerase TMX3 Potentiates Platelet Aggregation and Arterial Thrombosis in Mice

    by Fengwu Chen, Xiaofeng Yan, Yuxin Zhang, Zhenzhen Zhao, Aizhen Yang, Yue Lu, Miao Jiang, Yue Han, Depei Wu, Yi Wu

    BACKGROUND: Several members of the PDI (protein disulfide isomerase) family have been shown to regulate platelet function and thrombosis. TMX3 (thioredoxin-related transmembrane protein 3), the sole transmembrane member of the PDI family containing catalytically inactive thioredoxin-like domains, has been implicated in thrombotic diseases, but its role in hemostasis and thrombosis remains uninvestigated. METHODS: We generated hematopoietic and endothelial cell-specific (Tie2-Cre) and platelet-specific (Pf4-Cre) TMX3 conditional knockout mice to assess the contribution of TMX3 to hemostasis and thrombosis. The functions of TMX3 in platelet aggregation, granule secretion, spreading, clot retraction, and calcium mobilization were examined. Wild-type and catalytically inactive TMX3 proteins were produced to determine the catalytic capacity of TMX3 toward αIIbβ3. Calcium ionophore, eptifibatide, ADP, and apyrase were used to investigate the regulatory mechanisms of TMX3 in platelet granule secretion. RESULTS: Expression of TMX3 on the platelet surface increased with convulxin stimulation. TMX3 knockout mice exhibited prolonged tail-bleeding times and decreased platelet accumulation in both FeCl 3 - and laser-induced thrombosis models. TMX3-deficient platelets had decreased P-selectin expression, αIIbβ3 activation, platelet aggregation, and ATP release, while maintaining normal platelet spreading, clot retraction, granule biogenesis, and Ca 2+ mobilization. Mechanistically, TMX3 bound tightly to αIIbβ3 and generated thiols in αIIb and β3, particularly in αIIb. Meanwhile, TMX3 regulated calcium mobilization-triggered platelet dense granule secretion, independent of αIIbβ3-mediated outside-in signaling. The impaired aggregation of TMX3-deficient platelets resulted from defective ADP release. Recombinant catalytically inactivated TMX3 protein inhibited platelet aggregation and ATP release and significantly reduced platelet accumulation and fibrin deposition in the laser-induced thrombosis model, whereas recombinant wild-type TMX3 protein neither enhanced human platelet aggregation and ATP release nor rescued the impaired aggregation and ATP release of TMX3-deficient platelets. CONCLUSIONS: Our data highlight a critical role for TMX3 in platelet function and thrombus formation by interacting with αIIbβ3 integrin and directly regulating platelet granule secretion.

  • Open Access

    Functional Characterization of the VWF p.Cys2163Tyr Variant Reveals Impaired Secretion and Intracellular Processing

    by Yuxin Zhang, Yingkun Zhang, Aizhen Yang, Yabei Zuo, Xiaofeng Yan, Feifei Zhang, Yan Wang, Zhiyun Niu, Fengwu Chen, Yi Wu, et al.

    Von Willebrand disease (VWD) is the most common inherited bleeding disorder, yet the contribution of specific VWF domains to its pathogenesis remains incompletely understood. In particular, the role of the D4 domain in VWF secretion, intracellular maturation, and multimer formation has not been fully elucidated. Here, we investigated the functional impact of a heterozygous p.Cys2163Tyr variant located in the D4 domain, identified in a patient with a severe bleeding phenotype, using clinical evaluation, genetic analysis, family studies, and in vitro expression assays. Laboratory testing revealed markedly reduced VWF:Ag (6.8 IU/dL), VWF:GPIbR (0.1 IU/dL), and FVIII:C levels, indicating a severe VWD phenotype in the proband. Plasma VWF multimer analysis showed a markedly reduced overall VWF signal with an almost complete absence of high-molecular-weight multimers, supporting classification of the phenotype as severe type 2A VWD. The heterozygous c.6488G>A (p.Cys2163Tyr) variant was also present in asymptomatic family members, indicating incomplete segregation with the severe phenotype and suggesting that this variant alone is insufficient to explain the proband’s disease severity. Notably, the proband’s mother exhibited mildly reduced VWF levels in the absence of this variant, suggesting the possible contribution of an additional unidentified defect or modifier affecting the maternal allele. In vitro expression demonstrated preserved intracellular VWF antigen, markedly reduced secretion of mutant VWF, and loss of high-molecular-weight VWF multimers. Together, these findings indicate that VWF p.Cys2163Tyr is a functionally deleterious variant that markedly impairs VWF secretion and high-molecular-weight multimer formation in vitro. However, the incomplete segregation observed in the family suggests that this heterozygous variant alone may not fully account for the proband’s severe type 2A VWD phenotype.


  • Open Access

    Differential transport pathways of saturated and unsaturated fatty acid esters in male mouse hepatocytes

    by Fengwu Chen, Aizhen Yang, Yue Lu, Yuxin Zhang, Jingyu Zhang, Jianan Bu, Runlin Guo, Yue Han, Depei Wu, Yi Wu

    Saturated fatty acid (SFA) and unsaturated fatty acid (UFA) have distinct impacts on health. Whether SFA and UFA are differentially transported in liver remains elusive. Here, we find the secretion of UFA but not SFA esters is retarded in a male mouse hepatic endoplasmic reticulum (ER) stress model. Among 13 members of protein disulfide isomerase (PDI) family, only PDIA1 (PDI) deficiency leads to hepatosteatosis and hypolipidemia. In PDI-deficient male mouse liver, there is a severe accumulation but secretory blockade of UFA esters, whereas the accumulation and secretion of SFA esters remain normal. PDI catalyzes the oxidative folding of microsomal triglyceride transfer protein (MTP). In addition, PDI deficiency in hepatocytes abolishes Apolipoprotein B-100 (ApoB-100) very low-density lipoprotein (VLDL) secretion while maintaining partial ApoB-48 VLDL secretion. In summary, we find that the secretion of UFA esters is PDI-MTP indispensable, while SFA esters could be transferred out of liver via ApoB-48 VLDL through a PDI-MTP-independent pathway.